ARCHIVES

“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers

This article is from The Cancer Letter archive.

Vol. 07 No. 16 | April 17, 1981

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

HPV Can Affect Response To Radiation Therapies

September 28, 2012

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992

UICC Receives 1300 Abstracts For Congress In Oslo, Norway.

February 22, 2002

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

Statistics Review Shows Improved Mortality Under 65, Through 1986

January 19, 1990